Healthcare stocks outperformed the Russell 1000 (20.3% vs. 15.5%). The healthcare sector has caught investors' attention since some of these companies have received regulatory approval for drugs to treat COVID-19 and begun distributing vaccines.

Several healthcare companies classified as penny stocks have been hitting key milestones in several fields. These companies require immediate attention from healthcare investors.

Wearable Health Solutions (OTCMKTS:WHSI) recently announced the launch date for its highly-anticipated iHelp MAX 4G cellular PERS device. Sold directly through WHSI's network of dealers and distributors, the iHelp MAX 4G will be available to customers in June of 2022.

The much-lauded emergency medical device will include such improved features as:

· 	Fall Detection,
· 	Geo-Fencing,
· 	AI Utilizing Google Assistant and Alexa,
· 	Notifications, Daily Check-Ins, and Medication Reminders

WHSI's commitment to this device has been covered in the media and is expected to bring success to WHSI as it provides calm and comfort to its customers. With an ever-growing market of independent senior citizens and lone workers, the need for WHSI's iHelp MAX 4G product is at an all-time high.

Dealer Portal Allows for Easy, Intuitive Data Transmission

With the knowledge of its growing market, WHSI has made it easier than ever for customers to find its products through its dealer network. WHSI's dealers are able to take advantage of the industry-wide competitive advantage WHSI's new dealer portal provides. In its 2021 acquisition of mHealthCentral's assets and its technology, WHSI created additional layers of support, utility, and competition for its iHelp MAX 4G PERS device.

The back-end-as-a-service (BAAS) allows for intuitive methods of data transmission from the PERS devices and retransmits that data to the appropriate parties (subscribers, monitoring centers, healthcare providers, Front-End Portal & User Interfaces, and API controllers). Ease of transmission between parties is paramount for WHSI to compete in the growing PERS marketplace.

Making data easier to transmit improves the user experience, provides greater insight into health, and provides for greater security and more accurate and speedy response time in case of an emergency.

Worldwide Business with kathy ireland® Boosts Exposure

WHSI has been selected to appear on Worldwide

Business with kathy ireland® to discuss their Next Generation Medical Alert Technology.

In a concerted effort to get its product in front of its customer base, WHSI was interviewed by modeling legend and business icon Kathy Ireland in February 2022. WHSI's appearance on the show will air later this year - stay tuned for updates. This appearance will help in driving leads within the wearable health market to WHSI's network of distributors and dealers.

Through Ireland's broadcast network, WHSI could potentially find itself in front of more than 200 million potential customers. Carried on Fox Business Network and Bloomberg International Television as branded content, and with video available on social media outlets, Worldwide Business with kathy ireland® is creating compelling video content for WHSI's iHelp MAX 4G PERS product.

Start your research on WHSI today.

Kaleido Biosciences (NASDAQ:KLDO) - Not too long ago, the Kaleido Biosciences stock had gone through a considerable slump but it has since made a strong recovery and on Wednesday, the stock soared by as much as 75% amidst heavy interest.

The company came into focus earlier this week on Monday after it announced that it had submitted a filing to the United States Securities and Exchange Commission with regards to the ceasing of all its business operations. The company went on to note that it was also going to lay off all of its staff and was also going to get its stock delisted from the Nasdaq exchange.

Agile Therapeutics Inc (NASDAQ:AGRX) - Women's healthcare company Agile Therapeutics is another company that may be considered by investors at this point.

Earlier this week on April 11 the company was in the news after it announced that it had received as much as $4.7 million in the form of net proceeds after selling its tax benefits under the provisions of the New Jersey Economic Development Authority (NJEDA) Net Operating Loss (NOL) initiative. The initiative was started under the auspices of the New Jersey Recovery Act 2000. It may be a good move now to add the stock to your watch lists.

PolarityTE Inc (NASDAQ:PTE) - The biotechnology firm PolarityTE is best known for its work on the development of products for regenerating tissues and for biomaterials. Back on March 30, the company had come into focus after it announced its financial results for the fiscal year that had ended on December 31, 2021.

The company suffered a net loss to the tune of $33.7 million in the fiscal year but that was a considerable improvement of 27% from the loss of $45.9 million in the previous fiscal year. It may be a good time to keep an eye on it.

Akebia Therapeutics (NASDAQ:AKBA) - Lastly, it is the Akebia Therapeutics stock that could be worth keeping an eye on at this point in time. Last month the approval process for its potential blockbuster product vadadustat had been scuppered after safety concerns had been raised.

However, the company is working on a solution and last week it announced that it was going to have a restructure the process so that the whole situation could be remedied. The company also laid off as much as 50% of its staff and noted that there were deeper factors at play with regard to the FDA.

CAPITAL GAINS REPORT

Capital Gains Report is a leading firm providing research for retail investors, through industry reports, CEO interviews, podcasts and more www.CapitalGainsReport.com. Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here:

https://tinyurl.com/2p92mpv4

CONTACT: To educate and attract more investors contact us at:

Mark McKelvie

mark@capitalgainsreport.com

(754) 233-0966

.

(C) 2022 M2 COMMUNICATIONS, source M2 PressWIRE